Zurich Consensus: Statement of German experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)

Michael Untch; Bernd Gerber; Volker Möbus; Andreas Schneeweiss; Christoph Thomssen; Gunter Von Minckwitz; Matthias W. Beckmann; Jens Uwe Blohmer; Serban Dan Costa; Klaus Diedrich; Ingo Diel; Wolfgang Eiermann; Klaus Friese; Nadia Harbeck; Jörn Hilfrich; Christian Jackisch; Wolfgang Janni; Fritz Jänicke; Walter Jonat; Manfred Kaufmann; Marion Kiechle; Uwe Köhler; Rolf Kreienberg; Nicolai Maass; Norbert Marschner; Ulrike Nitz; Anton Scharl; Diethelm Wallwiener

doi:10.1159/000327999

Zurich Consensus: Statement of German experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)

Michael Untch^*, Bernd Gerber, Volker Möbus, Andreas Schneeweiss, Christoph Thomssen, Gunter Von Minckwitz, Matthias W. Beckmann, Jens Uwe Blohmer, Serban Dan Costa, Klaus Diedrich, Ingo Diel, Wolfgang Eiermann, Klaus Friese, Nadia Harbeck, Jörn Hilfrich, Christian Jackisch, Wolfgang Janni, Fritz Jänicke, Walter Jonat, Manfred KaufmannMarion Kiechle, Uwe Köhler, Rolf Kreienberg, Nicolai Maass, Norbert Marschner, Ulrike Nitz, Anton Scharl, Diethelm Wallwiener

^*Corresponding author for this work

Clinic of Gynecology and Obstetrics

4 Citations (Scopus)

Abstract

Every 2 years, the International Consensus Conference on the Treatment of Primary Breast Cancer takes place in St. Gallen. Given that the concept of the St. Gallen Consensus Conference mainly reflects an international opinion, it appears useful to adapt the results of the vote for everyday therapy in Germany. A German working group comprising 28 breast cancer experts, amongst whom there are 3 members of the international St. Gallen panel, has therefore commented on this year's St. Gallen Consensus Conference (2011) from the German viewpoint. The focus of interest of this year's St. Gallen Conference was tumour biology as the starting point for decisions regarding individual therapy. There was an intensive discussion in relation to the clinical relevance of predictive and prognostic factors and possible consequences for decisions regarding therapy. Therefore, questions concerning the indication for adjuvant chemotherapy focused especially on the significance of the molecular phenotype of the tumour. In addition, important points for discussion were also the value of complete axillary dissection and the use of accelerated complete breast irradiation.

Original language	English
Journal	Breast Care
Volume	6
Issue number	2
Pages (from-to)	144-152
Number of pages	9
ISSN	1661-3791
DOIs	https://doi.org/10.1159/000327999
Publication status	Published - 01.04.2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1159/000327999

Cite this

Untch, M., Gerber, B., Möbus, V., Schneeweiss, A., Thomssen, C., Von Minckwitz, G., Beckmann, M. W., Blohmer, J. U., Costa, S. D., Diedrich, K., Diel, I., Eiermann, W., Friese, K., Harbeck, N., Hilfrich, J., Jackisch, C., Janni, W., Jänicke, F., Jonat, W., ... Wallwiener, D. (2011). Zurich Consensus: Statement of German experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011). Breast Care, 6(2), 144-152. https://doi.org/10.1159/000327999

@article{592a89d9f09c42d98121f96d1394712e,

title = "Zurich Consensus: Statement of German experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)",

abstract = "Every 2 years, the International Consensus Conference on the Treatment of Primary Breast Cancer takes place in St. Gallen. Given that the concept of the St. Gallen Consensus Conference mainly reflects an international opinion, it appears useful to adapt the results of the vote for everyday therapy in Germany. A German working group comprising 28 breast cancer experts, amongst whom there are 3 members of the international St. Gallen panel, has therefore commented on this year's St. Gallen Consensus Conference (2011) from the German viewpoint. The focus of interest of this year's St. Gallen Conference was tumour biology as the starting point for decisions regarding individual therapy. There was an intensive discussion in relation to the clinical relevance of predictive and prognostic factors and possible consequences for decisions regarding therapy. Therefore, questions concerning the indication for adjuvant chemotherapy focused especially on the significance of the molecular phenotype of the tumour. In addition, important points for discussion were also the value of complete axillary dissection and the use of accelerated complete breast irradiation.",

author = "Michael Untch and Bernd Gerber and Volker M{\"o}bus and Andreas Schneeweiss and Christoph Thomssen and {Von Minckwitz}, Gunter and Beckmann, {Matthias W.} and Blohmer, {Jens Uwe} and Costa, {Serban Dan} and Klaus Diedrich and Ingo Diel and Wolfgang Eiermann and Klaus Friese and Nadia Harbeck and J{\"o}rn Hilfrich and Christian Jackisch and Wolfgang Janni and Fritz J{\"a}nicke and Walter Jonat and Manfred Kaufmann and Marion Kiechle and Uwe K{\"o}hler and Rolf Kreienberg and Nicolai Maass and Norbert Marschner and Ulrike Nitz and Anton Scharl and Diethelm Wallwiener",

year = "2011",

month = apr,

day = "1",

doi = "10.1159/000327999",

language = "English",

volume = "6",

pages = "144--152",

journal = "Breast Care",

issn = "1661-3791",

number = "2",

}

Untch, M, Gerber, B, Möbus, V, Schneeweiss, A, Thomssen, C, Von Minckwitz, G, Beckmann, MW, Blohmer, JU, Costa, SD, Diedrich, K, Diel, I, Eiermann, W, Friese, K, Harbeck, N, Hilfrich, J, Jackisch, C, Janni, W, Jänicke, F, Jonat, W, Kaufmann, M, Kiechle, M, Köhler, U, Kreienberg, R, Maass, N, Marschner, N, Nitz, U, Scharl, A & Wallwiener, D 2011, 'Zurich Consensus: Statement of German experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)', Breast Care, vol. 6, no. 2, pp. 144-152. https://doi.org/10.1159/000327999

TY - JOUR

T1 - Zurich Consensus: Statement of German experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)

AU - Untch, Michael

AU - Gerber, Bernd

AU - Möbus, Volker

AU - Schneeweiss, Andreas

AU - Thomssen, Christoph

AU - Von Minckwitz, Gunter

AU - Beckmann, Matthias W.

AU - Blohmer, Jens Uwe

AU - Costa, Serban Dan

AU - Diedrich, Klaus

AU - Diel, Ingo

AU - Eiermann, Wolfgang

AU - Friese, Klaus

AU - Harbeck, Nadia

AU - Hilfrich, Jörn

AU - Jackisch, Christian

AU - Janni, Wolfgang

AU - Jänicke, Fritz

AU - Jonat, Walter

AU - Kaufmann, Manfred

AU - Kiechle, Marion

AU - Köhler, Uwe

AU - Kreienberg, Rolf

AU - Maass, Nicolai

AU - Marschner, Norbert

AU - Nitz, Ulrike

AU - Scharl, Anton

AU - Wallwiener, Diethelm

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Every 2 years, the International Consensus Conference on the Treatment of Primary Breast Cancer takes place in St. Gallen. Given that the concept of the St. Gallen Consensus Conference mainly reflects an international opinion, it appears useful to adapt the results of the vote for everyday therapy in Germany. A German working group comprising 28 breast cancer experts, amongst whom there are 3 members of the international St. Gallen panel, has therefore commented on this year's St. Gallen Consensus Conference (2011) from the German viewpoint. The focus of interest of this year's St. Gallen Conference was tumour biology as the starting point for decisions regarding individual therapy. There was an intensive discussion in relation to the clinical relevance of predictive and prognostic factors and possible consequences for decisions regarding therapy. Therefore, questions concerning the indication for adjuvant chemotherapy focused especially on the significance of the molecular phenotype of the tumour. In addition, important points for discussion were also the value of complete axillary dissection and the use of accelerated complete breast irradiation.

AB - Every 2 years, the International Consensus Conference on the Treatment of Primary Breast Cancer takes place in St. Gallen. Given that the concept of the St. Gallen Consensus Conference mainly reflects an international opinion, it appears useful to adapt the results of the vote for everyday therapy in Germany. A German working group comprising 28 breast cancer experts, amongst whom there are 3 members of the international St. Gallen panel, has therefore commented on this year's St. Gallen Consensus Conference (2011) from the German viewpoint. The focus of interest of this year's St. Gallen Conference was tumour biology as the starting point for decisions regarding individual therapy. There was an intensive discussion in relation to the clinical relevance of predictive and prognostic factors and possible consequences for decisions regarding therapy. Therefore, questions concerning the indication for adjuvant chemotherapy focused especially on the significance of the molecular phenotype of the tumour. In addition, important points for discussion were also the value of complete axillary dissection and the use of accelerated complete breast irradiation.

UR - http://www.scopus.com/inward/record.url?scp=79957598192&partnerID=8YFLogxK

U2 - 10.1159/000327999

DO - 10.1159/000327999

M3 - Journal articles

AN - SCOPUS:79957598192

SN - 1661-3791

VL - 6

SP - 144

EP - 152

JO - Breast Care

JF - Breast Care

IS - 2

ER -

Zurich Consensus: Statement of German experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this